LANDUCCI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 3.491
NA - Nord America 3.171
AS - Asia 542
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.216
Nazione #
US - Stati Uniti d'America 3.163
PL - Polonia 2.305
IT - Italia 347
IE - Irlanda 326
SE - Svezia 248
CN - Cina 181
HK - Hong Kong 159
CH - Svizzera 54
SG - Singapore 54
JO - Giordania 52
RU - Federazione Russa 40
VN - Vietnam 40
FI - Finlandia 39
TR - Turchia 38
GB - Regno Unito 36
DE - Germania 35
UA - Ucraina 18
FR - Francia 14
BE - Belgio 12
CA - Canada 8
KR - Corea 7
ES - Italia 6
IN - India 6
NL - Olanda 5
MU - Mauritius 4
EU - Europa 3
JP - Giappone 3
EG - Egitto 2
HU - Ungheria 2
NG - Nigeria 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IR - Iran 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 7.216
Città #
Warsaw 2.304
Fairfield 504
Dublin 322
Chandler 321
Ashburn 268
Woodbridge 243
Seattle 219
Cambridge 191
Wilmington 178
Houston 174
Ann Arbor 145
Florence 102
Hong Kong 100
Lawrence 87
Altamura 85
Beijing 83
Princeton 72
Bern 52
Shanghai 48
Buffalo 43
Boston 42
Dearborn 42
San Diego 37
Dong Ket 36
Medford 35
Singapore 31
Boardman 28
Moscow 28
Phoenix 21
Jacksonville 18
Falls Church 17
Kent 15
Brussels 12
London 12
Rome 12
Turin 11
Milan 10
New York 10
Hillsboro 9
Norwalk 9
Izmir 7
Naples 7
Redmond 7
Seoul 6
West Jordan 6
Toronto 5
Andover 4
Barcelona 4
Bremen 4
Lappeenranta 4
Laurel 4
Los Angeles 4
Nanjing 4
Paris 4
Redwood City 4
Castelliri 3
Chennai 3
Ferrara 3
Hefei 3
Ottawa 3
Pescara 3
Washington 3
Agliana 2
Bologna 2
Böblingen 2
Cagliari 2
Cascina 2
Catanzaro 2
Fucecchio 2
Gallarate 2
Giza 2
Gorgonzola 2
Guangzhou 2
Hangzhou 2
Jinan 2
Livorno 2
Massa 2
Naaldwijk 2
Nagold 2
Napoli 2
Ningbo 2
Pearsall 2
Pisa 2
Pontedera 2
Pune 2
Sassuolo 2
Seriate 2
Sermoneta 2
Tokyo 2
Avellino 1
Bloomington 1
Bovisio Masciago 1
Brentford 1
Campi Bisenzio 1
Changsha 1
Chengdu 1
Collecchio 1
Dallas 1
Elkins Park 1
Ergolding 1
Totale 6.136
Nome #
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism 252
3-Iodothyroacetic acid (TA1), a by-product of thyroid hormone metabolism, reduces the hypnotic effect of ethanol without interacting at GABA-A receptors. 233
The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice 226
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 223
In the brain of mice,3-iodothyronamine(T1AM) is converted into 3-iodothyroaceticacid(TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 223
Arrays of MicroLEDs and Astrocytes: Biological Amplifiers to Optogenetically Modulate Neuronal Networks Reducing Light Requirement 217
Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance 213
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold 207
Glutamate receptor and transporter modifications in rat organotypic hippocampal slice cultures exposed to oxygen-glucose deprivation: The contribution of cyclooxygenase-2 202
Interplay between histone acetylation/deacetylation and poly(ADPribosyl)ation in the development of ischemic tolerance in vitro 201
Anticonvulsant and Neuroprotective Effects of the Thyroid Hormone Metabolite 3-Iodothyroacetic Acid. 199
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability 197
Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo 196
The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models 178
Brain histamine modulates the antidepressant-like effect of the 3-iodothyroacetic acid (TA1) 163
Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. 159
Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases. 153
Bicuculline Reverts the Neuroprotective Effects of Meloxicam in an Oxygen and Glucose Deprivation (OGD) Model of Organotypic Hippocampal Slice Cultures 150
Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue. 148
Glutamate Receptor-Mediated Neurotoxicity in a Model of Ethanol Dependence and Withdrawal in Rat Organotypic Hippocampal Slice Cultures 142
Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors 137
Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin 137
Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain 127
Using organotypic hippocampal slice cultures to gain insight into mechanisms responsible for the neuroprotective effects of meloxicam: A role for gamma aminobutyric and endoplasmic reticulum stress 126
N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity 124
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 112
A new ophthalmic formulation containing antiseptics and dexpanthenol: In vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells 106
Rat hippocampal slice culture models for the evaluation of neuroprotective agents. 104
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors 101
Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K–Akt signaling pathway: A novel postconditioning strategy? 92
Enhanced Neuroprotective Effects of Panax Ginseng G115® and Ginkgo Biloba GK501® Combinations In Vitro Models of Excitotoxicity 88
Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance 86
3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes. 85
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study 83
Ethanol Toxicity During Brain Development: Alterations of Excitatory Synaptic Transmission in Immature Organotypic Hippocampal Slice Cultures 82
BRAIN-TARGETED DELIVERY OF ANDROGRAPHOLIDE USING SOLID LIPID NANOPARTICLES: IN VITRO AND IN VIVO EVALUATION 82
CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices 78
Differential mechanisms of tolerance induced by NMDA and DHPG preconditioning 72
Tolerance Induced by (S)-3,5-Dihydroxyphenylglycine Postconditioning is Mediated by the PI3K/Akt/GSK3β Signalling Pathway in an In Vitro Model of Cerebral Ischemia 71
Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization 70
Neurotoxicity of Unconjugated Bilirubin in Mature and Immature Rat Organotypic Hippocampal Slice Cultures 70
Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation 66
Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur Citrus Extract 60
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 57
Preconditioning with NMDA, but not DHPG, induces tolerance to excitotoxicity by internalization of AMPA receptors. 57
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia 53
Nerve Growth Factor mimetics with neuroprotective activity in ischemic brain damage 52
Preconditioning With NMDA and DHPG Induces Ischemic Tolerance With Differential Mechanisms In An In Vitro Hippocampal Slice Model Of Excitotoxicity 52
Applications of innovative technologies to the antipsychotics delivery. 50
Interplay between group I mGlu and the endocannabinoid system in the hippocampus: studies in models of cerebral ischemia 49
mGlu1 receptors and endocannabinoids: neuroprotection studies in an in vitro model of cerebral ischemia 48
DHPG and NMDA preconditioning induce ischemic tolerance with differential mechanisms 47
Nerve growth factor (NGF) mimetics modulate ischemic brain damage 45
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia 43
Mild activation of ionotropic and metabotropic glutamate receptors induces ischemic tolerance with differential mechanisms in rat organotypic hippocampal slices 43
Neuroprotective effects of cannabidiol but not Δ9-tetrahydrocannabinol in rat hippocampal slices exposed to oxygen-glucose deprivation: studies with Cannabis extracts and selected cannabinoids. 43
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. 42
Neuroprotective effects of thymoquinone by the modulation of ER stress and apoptotic pathway in in vitro model of excitotoxicity. 41
An electrophysiological study of the mGlu1 receptors ability to modulate endocannabinoids production and inhibitory synaptic transmission in the CA1 hippocampal area 40
Improved super-bright microLEDs for bi-dimensional optogenetic applications and opto-electronic retinal prosthesis. 39
MPP+-dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons 39
Preparation of liposomal formulations for ocular delivery of thymoquinone: in vitro evaluation in HCEC-2 e HConEC cells. 39
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: in vitro test and in vivo toxicity assessment in Zebrafish embryos. 38
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: an electrophysiological study 37
Preconditioning with NMDA and DHPG induces ischemic tolerance with differential mechanisms in an in vitro hippocampal slice model 37
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model 35
NMDA and DHPG preconditioning induce ischemic tolerance with differential mechanisms in rat organotypic hippocampal slices 34
Interplay between mGlu1 and CB1 receptors in the postischemic CA1 hippocampal area: Neuroprotection and anatomical studies. 29
Neuroprotection following postconditioning via group I mGlu receptor activation is coupled to the PI3K/Akt/GSK3β signalling pathway in a rat organotypic hippocampal slice model of cerebral ischemia 29
Evaluation of Conventional and Hyaluronic Acid-Coated Thymoquinone Liposomes in an In Vitro Model of Dry Eye 27
Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol 26
Virtual screening and in vitro experiments highlight cannabidiol as a drug-like phosphodiesterase 9 inhibitor 25
The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism 21
Cannabidiol preferentially binds TRPV2: a novel mechanism of action 21
The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation 20
Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model 18
Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy 11
Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases 5
Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model 1
Totale 7.334
Categoria #
all - tutte 21.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.865 118 165 60 126 223 203 213 222 175 157 170 33
2020/20211.264 108 148 37 149 105 106 71 90 121 211 54 64
2021/2022514 17 29 34 18 14 47 35 35 29 32 88 136
2022/20231.514 116 264 82 84 107 249 192 90 197 14 49 70
2023/2024645 19 76 88 24 60 68 36 143 17 33 55 26
2024/202580 80 0 0 0 0 0 0 0 0 0 0 0
Totale 7.334